OTCMKTS:PVOTF BetterLife Pharma (PVOTF) Stock Price, News & Analysis → Make This $3 Trade the Instant the Opening Bell Rings (From Monument Traders Alliance) (Ad) Free PVOTF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.13▼$0.1352-Week Range N/AVolume198,200 shsAverage Volume52,703 shsMarket Capitalization$21.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BetterLife Pharma alerts: Email Address Ad Monument Traders AllianceMake This $3 Trade the Instant the Opening Bell RingsSince the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 About BetterLife Pharma Stock (OTCMKTS:PVOTF)BetterLife Pharma, Inc. is an early stage pharmaceutical company, which engages in the development and commercialization of therapeutic pharmaceutical and nutraceutical products. It also offers drug delivery platform technologies. Its product lines include capsules, tablets, and softgels; bulk powder; stick packs; beverages; oral solutions; lotions, creams, and gels; pet food additives; gum, mints, and candies; and sexual health products. It distributes its product under the Pivot Naturals brand. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.Read More Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. PVOTF Stock News HeadlinesMarch 4, 2024 | finanznachrichten.deBetterLife Pharma Inc.: BetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityFebruary 5, 2024 | theguardian.comThe tragedy of Leonard Farruku, the gifted young musician whose dream of a better life ended on the Bibby StockholmMarch 18, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.February 1, 2024 | msn.comWeight loss drugs could create the first $1 trillion pharma companiesJanuary 2, 2024 | finance.yahoo.comBetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001November 16, 2023 | msn.comBig Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity ratesNovember 15, 2023 | tmcnet.comUS Patent and Trademark Office Publishes BetterLife's Comprehensive Patent for BETR-001 and Other LSD DerivativesNovember 13, 2023 | businesswire.comMedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)March 18, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.October 25, 2023 | finance.yahoo.comLi3 Lithium Announces Appointment of Robert Metcalfe to the Board of DirectorsJune 28, 2023 | msn.comBetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD DerivativesMarch 12, 2023 | finance.yahoo.comEsperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQJanuary 26, 2023 | benzinga.comBetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial ProgramsJanuary 22, 2023 | ca.finance.yahoo.comBetterLife Pharma Inc. (BETR.CN)June 21, 2022 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) ForumSee More Headlines Receive PVOTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:PVOTF Previous SymbolOTCMKTS:PVOTF CUSIPN/A CIK1464165 Webpivotpharma.com Phone(604) 805-7783FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-205.15% Return on Assets-147.23% Debt Debt-to-Equity RatioN/A Current Ratio3.62 Quick Ratio3.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares171,414,000Free FloatN/AMarket Cap$21.70 million OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesAhmad DoroudianChief Executive Officer & DirectorChris LuckyChief Operating OfficerMoira OngChief Financial OfficerKey CompetitorsOncternal TherapeuticsNASDAQ:ONCTLumos PharmaNASDAQ:LUMOGreen Organic DutchmanOTCMKTS:TGODFNicoxOTCMKTS:NICXFCovalon TechnologiesOTCMKTS:CVALFView All Competitors PVOTF Stock Analysis - Frequently Asked Questions How do I buy shares of BetterLife Pharma? Shares of PVOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PVOTF) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.